Skip to main content

Want a detailed portfolio tracker?

Amphastar Pharmaceuticals (AMPH) Free Cash Flow (2017 - 2026)

Amphastar Pharmaceuticals (AMPH) free cash flow from Sep 30, 2017 to Mar 31, 2026. The TTM Amphastar Pharmaceuticals (AMPH) free cash flow is $135M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Free Cash Flow

Quarterly Free Cash Flow

Amphastar Pharmaceuticals (AMPH) Free Cash Flow CAGR table

PeriodCAGR
1 Year TTM-10.02%
3 Years TTM+37.99%
5 Years TTM+24.52%

Annual Free Cash Flow change of Amphastar Pharmaceuticals (AMPH)

YearFree Cash FlowChange
2026$38M-68.39%
2025$121M-29.65%
2024$172M+18.59%
2023$145M+123.07%
2022$65M-7.63%
2021$71M+201.15%
2020$23M+11610.00%
2019$200K-102.32%
2018-$8.62M-309.73%
2017$4.11M-76.08%
2016$17MN/A

Comparison Amphastar Pharmaceuticals (AMPH) five years free cash flow CAGR with competitors

Amphastar Pharmaceuticals (AMPH) five years free cash flow CAGR is 24.53%.